Brazil allows trials of Chinese vaccine to resume

Sao Paulo (AFP) Nov 11, 2020

Brazil's national health regulator allowed clinical trials of a Chinese-developed Covid-19 vaccine to resume Wednesday, two days after suspending them in what critics called a decision tainted by politics. The regulatory agency, Anvisa, said it had now received more details on the nature of the "adverse incident" that led it to halt final-stage trials of the CoronaVac vaccine, and had "suffi